Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05968664 · ClinicalTrials.gov registry record · NA
Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation
A NA study of Chronic Pain and Neuropathic Pain, sponsored by Ashwin Viswanathan.
- Recruiting
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT05968664: Recruiting NA study of Chronic Pain and Neuropathic Pain, sponsored by Ashwin Viswanathan.
NCT05968664 is a NA study of Chronic Pain and Neuropathic Pain that is actively recruiting participants, run by Ashwin Viswanathan. The registered enrollment target is 43 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05968664, a NA study of Chronic Pain and Neuropathic Pain, is actively recruiting participants, sponsored by Ashwin Viswanathan.
- RECRUITING
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare pain outcomes achieved by spinal cord stimulation (SCS) using time varying stimulation patterns with pain outcomes achieved by current standard of care SCS.
Primary Outcome
The primary endpoint for this trial will be a comparison of the percentage of patients achieving at least a 50% reduction in pain during the TIP stimulation block with the percentage of patients achieving at least a 50% reduction in pain during either TVP stimulation block.
Conditions Studied
Interventions
- DEVICE Spinal Cord Stimulator
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT05968664 shows while recruiting
NCT05968664 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulator is the first listed.
NCT05968664 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05968664 about?
NCT05968664 is a clinical study titled "Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation". The goal of this study is to compare pain outcomes achieved by spinal cord stimulation (SCS) using time varying stimulation patterns with pain outcomes achieved by current standard of care SCS.
What is the current status of trial NCT05968664?
This trial is currently recruiting. It is a NA study. The enrollment target is 43 participants. The study started on 2024-08-01. Estimated completion is 2028-01.
What conditions does trial NCT05968664 study?
This clinical trial studies the following conditions: Chronic Pain, Neuropathic Pain, Pain, Neuropathic.
What interventions are being tested in trial NCT05968664?
The interventions under investigation include: Spinal Cord Stimulator (DEVICE).
Who is sponsoring clinical trial NCT05968664?
This trial is sponsored by Ashwin Viswanathan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05968664 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05968664's enrollment target sits among peer trials
43 211th of 301 higher than 91 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI